Wen Zhou, MD, PhD

AbbVie Inc.

Poster(s):

• B0417 - Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study
  Monday, October 24, 2022

  10:00 AM – 12:00 PM ET